Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
Resource URI: https://dblp.l3s.de/d2r/resource/publications/journals/cbm/KrishnamoorthyMYPM23
Home
|
Example Publications
Property
Value
dcterms:
bibliographicCitation
<
http://dblp.uni-trier.de/rec/bibtex/journals/cbm/KrishnamoorthyMYPM23
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Bharathi_Muruganantham
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Jae-Ran_Yu
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Sneha_Krishnamoorthy
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Sridhar_Muthusami
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Woo-Yoon_Park
>
foaf:
homepage
<
http://dx.doi.org/doi.org%2F10.1016%2Fj.compbiomed.2023.107592
>
foaf:
homepage
<
https://doi.org/10.1016/j.compbiomed.2023.107592
>
dc:
identifier
DBLP journals/cbm/KrishnamoorthyMYPM23
(xsd:string)
dc:
identifier
DOI doi.org%2F10.1016%2Fj.compbiomed.2023.107592
(xsd:string)
dcterms:
issued
2023
(xsd:gYear)
swrc:
journal
<
https://dblp.l3s.de/d2r/resource/journals/cbm
>
rdfs:
label
Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
(xsd:string)
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Bharathi_Muruganantham
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Jae-Ran_Yu
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Sneha_Krishnamoorthy
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Sridhar_Muthusami
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Woo-Yoon_Park
>
swrc:
month
December
(xsd:string)
swrc:
pages
107592
(xsd:string)
owl:
sameAs
<
http://bibsonomy.org/uri/bibtexkey/journals/cbm/KrishnamoorthyMYPM23/dblp
>
owl:
sameAs
<
http://dblp.rkbexplorer.com/id/journals/cbm/KrishnamoorthyMYPM23
>
rdfs:
seeAlso
<
http://dblp.uni-trier.de/db/journals/cbm/cbm167.html#KrishnamoorthyMYPM23
>
rdfs:
seeAlso
<
https://doi.org/10.1016/j.compbiomed.2023.107592
>
dc:
title
Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
(xsd:string)
dc:
type
<
http://purl.org/dc/dcmitype/Text
>
rdf:
type
swrc:Article
rdf:
type
foaf:Document
swrc:
volume
167
(xsd:string)